Change-a Multi-center Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Database in China
A Chinese Real-world Study to Investigate the Management Pattern and Outcomes of Chronic Thromboembolic Pulmonary Hypertension (CHANGE Study)
China-Japan Friendship Hospital
1,500 participants
Oct 1, 2015
OBSERVATIONAL
Conditions
Summary
The Change Database is a prospective, observational multi-center disease registry, which will collect data on patients with chronic thromboembolic pulmonary hypertension (CTEPH) in China. It aims to illustrate the epidemiology, management and long-term outcomes of CTEPH.
Eligibility
Inclusion Criteria4
- Patients must be diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH)
- Patients must be willing to provide informed consent
- Patients must meet the following criteria for CTEPH:
- a mean pulmonary artery pressures (mPAP) ≥20 mmHg combined with a pulmonary vascular resistance (PVR) ≥ 3 WU and pulmonary arterial wedge pressure (PAWP)≤ 15 mmHg documented at right heart catheterization with radiographic evidence of organized thrombi involving the pulmonary arteries after 3 months of effective anticoagulation.
Exclusion Criteria3
- Main cause of PH other than CTEPH
- Participation in a therapeutic clinical trial with an unknown drug;
- Withdrawal or lack of informed consent.
Interventions
A multidisciplinary team make the final treatments for patients with CTEPH depending on their disease and preferences.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05311072